125 related articles for article (PubMed ID: 24749352)
21. Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.
Safarinejad MR; Shafiei N; Safarinejad S
Med Oncol; 2011 Dec; 28 Suppl 1():S398-412. PubMed ID: 21046286
[TBL] [Abstract][Full Text] [Related]
22. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
Yi K; Yang L; Lan Z; Xi M
Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study.
Shen H; Spitz MR; Wang LE; Hong WK; Wei Q
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):397-401. PubMed ID: 11319182
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms of MTHFR and susceptibility to oesophageal adenocarcinoma in a Caucasian United Kingdom population.
Keld R; Thian M; Hau C; Sajid J; Kumar N; Ang Y
World J Gastroenterol; 2014 Sep; 20(34):12212-6. PubMed ID: 25232254
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of the polymorphism MTHFR A1298C and not MTHFR C677T is related to chromosomal aneuploidy in Brazilian Turner Syndrome patients.
Oliveira KC; Bianco B; Verreschi IT; Guedes AD; Galera BB; Galera MF; Barbosa CP; Lipay MV
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1374-81. PubMed ID: 19169497
[TBL] [Abstract][Full Text] [Related]
26. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer.
Kang S; Kim JW; Kang GH; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2005 Jan; 96(1):173-80. PubMed ID: 15589597
[TBL] [Abstract][Full Text] [Related]
27. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in breast cancer.
Zhong S; Chen Z; Yu X; Li W; Tang J; Zhao J
Mol Biol Rep; 2014 Sep; 41(9):5775-85. PubMed ID: 24973876
[TBL] [Abstract][Full Text] [Related]
28. The maternal homocysteine pathway is influenced by riboflavin intake and MTHFR polymorphisms without affecting the risk of orofacial clefts in the offspring.
Vujkovic M; Steegers EA; van Meurs J; Yazdanpanah N; van Rooij IA; Uitterlinden AG; Steegers-Theunissen RP
Eur J Clin Nutr; 2010 Mar; 64(3):266-73. PubMed ID: 19935819
[TBL] [Abstract][Full Text] [Related]
29. Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis.
Xu XJ; Zou LW; Wang DB
Mol Biol Rep; 2013 Jan; 40(1):255-62. PubMed ID: 23070908
[TBL] [Abstract][Full Text] [Related]
30. Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia.
Lambropoulos AF; Agorastos T; Foka ZJ; Chrisafi S; Constantinidis TC; Bontis J; Kotsis A
Cancer Lett; 2003 Mar; 191(2):187-91. PubMed ID: 12618332
[TBL] [Abstract][Full Text] [Related]
31. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and risk of esophageal cancer.
Zhao P; Lin F; Li Z; Lin B; Lin J; Luo R
Asian Pac J Cancer Prev; 2011; 12(8):2019-23. PubMed ID: 22292644
[TBL] [Abstract][Full Text] [Related]
32. MTHFR A1298C polymorphism is associated with cardiovascular risk in end stage renal disease in North Indians.
Poduri A; Mukherjee D; Sud K; Kohli HS; Sakhuja V; Khullar M
Mol Cell Biochem; 2008 Jan; 308(1-2):43-50. PubMed ID: 17899317
[TBL] [Abstract][Full Text] [Related]
33. Studying the association between methylenetetrahydrofolate reductase (MTHFR) 677 gene polymorphism, cardiovascular risk and lichen planus.
Rashed L; Abdel Hay R; AlKaffas M; Ali S; Kadry D; Abdallah S
J Oral Pathol Med; 2017 Nov; 46(10):1023-1029. PubMed ID: 28463405
[TBL] [Abstract][Full Text] [Related]
34. Allelic variations in 5, 10-methylenetetrahydrofolate reductase gene and susceptibility to cervical cancer in Indian women.
Nandan NK; Wajid S; Biswas S; Juneja SS; Rizvi M; Prakash R; Naqvi SH
Drug Metab Lett; 2008 Jan; 2(1):18-22. PubMed ID: 19356065
[TBL] [Abstract][Full Text] [Related]
35. MTHFR C677T and A1298C gene polymorphisms and their relation to homocysteine level in Egyptian children with congenital heart diseases.
Zidan HE; Rezk NA; Mohammed D
Gene; 2013 Oct; 529(1):119-24. PubMed ID: 23933414
[TBL] [Abstract][Full Text] [Related]
36. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
[TBL] [Abstract][Full Text] [Related]
37. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis.
Long S; Yang X; Liu X; Yang P
PLoS One; 2012; 7(12):e52381. PubMed ID: 23285018
[TBL] [Abstract][Full Text] [Related]
38. Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta-analysis.
Zhu J; Wu L; Kohlmeier M; Ye F; Cai W
Mol Med Rep; 2013 Sep; 8(3):919-27. PubMed ID: 23864153
[TBL] [Abstract][Full Text] [Related]
39. Methylenetetrahydrofolate reductase gene polymorphism in Indian stroke patients.
Kalita J; Srivastava R; Bansal V; Agarwal S; Misra UK
Neurol India; 2006 Sep; 54(3):260-3. PubMed ID: 16936384
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene.
Berkun Y; Levartovsky D; Rubinow A; Orbach H; Aamar S; Grenader T; Abou Atta I; Mevorach D; Friedman G; Ben-Yehuda A
Ann Rheum Dis; 2004 Oct; 63(10):1227-31. PubMed ID: 15361376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
